Collaborate Corporation aligns with high profile motor vehicle brands
Collaborate Corporation (ASX: CL8) has forged an agreement with Trivett Automotive Group, one of Australia’s largest prestige automotive dealers, representing 15 brands across 23 dealerships with annual sales of 25,000 vehicles.
The agreement will facilitate the promotion and rental of BMW, Jaguar, Mini and Land Rover vehicles to private and corporate customers through CL8’s DriveMyCar business unit.
From Trivett’s perspective it will allow potential buyers to experience a range of models sold from its Sydney and Melbourne dealerships, all of which are rarely available for rent through traditional car rental companies.
Importantly, Trivett Automotive is the retail unit of Inchcape Australia, a leading player in the automotive services sector operating in the distribution, retail and logistics markets. The group’s brand partners also include Rolls-Royce, Bentley, McLaren, Honda, Subaru and Mitsubishi.
Inchcape Australia is part of the Inchcape plc group of companies which is based in London. It is the world’s largest independent international automotive retailer with operations in nearly 30 countries.
Consequently, not only has CL8 aligned with a high profile Australian automotive group, but it has also potentially teamed up with a partner which could support international expansion.
Although it must be said that this is an early stage company and investors considering this stock for their portfolio should seek professional financial advice.
It is worth noting that this is the second deal with an Inchcape company, following the October 12 announcement of an agreement with Subaru.
The company’s chief executive, Chris Noone highlighted the importance of the group’s relationship with Inchcape in saying, “We are pleased to be expanding our relationship with Inchcape in this new deal with Trivett which provides customers of DriveMyCar with the opportunity to experience BMW, Mini, Jaguar and Land Rover vehicles in ways never before possible, but just as important is the fact that it demonstrates the group’s ability to strike material deals that provide a foundation for an increasing revenue trajectory.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.